Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound

被引:36
|
作者
Klawe, C. [1 ]
Maschke, M. [1 ]
机构
[1] Bruederkrankenhaus Trier, Dept Neurol & Neurophysiol, D-54292 Trier, Germany
关键词
Alzheimer's disease; Creutzfeld-Jakob disease; flupirtine; G-protein-activated inwardly rectifying K+ channels (GIRKs); Kv7; channels; multiple sclerosis; muscle; pain; potassium channels; selective neuronal potassium channel openers (SNEPCO); spasticity; METHYL-D-ASPARTATE; ORAL FLUPIRTINE; MUSCLE TONE; BACK-PAIN; EFFICACY; PHARMACOKINETICS; CHANNELS; MALEATE; RAT; BIOTRANSFORMATION;
D O I
10.1517/14656560902988528
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Flupirtine is a nonopioid drug without antipyretic or antiphlogistic properties and with a favorable tolerability. It constitutes a unique class within the group of nonsteroidal analgesics and displays a peculiar pharmacodynamic profile that invites the investigation of applications beyond the pain-relieving effect. Objective: This review describes and evaluates the pharmacologic and clinical literature regarding flupirtine and discusses its future potential. Methods: A search of the primary literature and conference abstracts was conducted using the keyword 'flupirtine'. Resulting articles were compiled and analyzed for this review. Results/conclusions: Although flupirtine has gained a firm place in the treatment of acute and chronic pain in various clinical settings since its introduction, a broader range of applications remains to be explored in clinical trials. Possible neuroprotective effects due to N-methyl-D-aspartate antagonistic proper-ties of flupirtine might be promising in the treatment of Creutzfeld-Jakob disease, Alzheimer's disease, and multiple sclerosis. Trials in these fields are forthcoming.
引用
收藏
页码:1495 / 1500
页数:6
相关论文
共 50 条
  • [1] DISCRIMINATIVE STIMULUS PROPERTIES OF FLUPIRTINE - A NOVEL NONOPIOID ANALGESIC
    SWEDBERG, MDB
    SHANNON, HE
    [J]. FEDERATION PROCEEDINGS, 1987, 46 (03) : 547 - 547
  • [2] Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist
    Osborne, NN
    Cazevieille, C
    Wood, JPM
    Nash, MS
    Pergande, G
    Block, F
    Kosinski, C
    Schwarz, M
    [J]. GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1998, 30 (03): : 255 - 263
  • [3] Flupirtine: A Less-Explored, Neglected Nonopioid Analgesic Response
    Kumar, Kanupriya
    [J]. ANESTHESIA AND ANALGESIA, 2018, 126 (04): : 1425 - 1425
  • [5] Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine
    Göbel, H
    Schmid, J
    Heinze, A
    Pergande, G
    [J]. SCHMERZ, 1999, 13 (05): : 324 - 331
  • [6] Brain Distribution and Metabolism of Flupirtine, a Nonopioid Analgesic Drug with Antiseizure Effects, in Neonatal Rats
    Patil, Madhoosudan A.
    Matter, Brock A.
    Raol, Yogendra H.
    Bourne, David W. A.
    Kelley, Ryan A.
    Kompella, Uday B.
    [J]. PHARMACEUTICS, 2018, 10 (04):
  • [7] INFLUENCE OF FLUPIRTINE, A NOVEL NONOPIOID ANALGESIC AGENT ON SOMATOSENSORY EVOKED-POTENTIALS IN RATS
    NAGYMAJTENYI, L
    NICKEL, B
    DESI, I
    SZELENYI, I
    [J]. EXPERIENTIA, 1992, 48 (10): : 992 - 993
  • [8] INVESTIGATIONS WITH THE NOVEL NONOPIOID ANALGESIC FLUPIRTINE IN REGARD TO POSSIBLE BENZODIAZEPINE-LIKE ABUSE INDUCING POTENTIAL
    NICKEL, B
    BORBE, HO
    SZELENYI, I
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-2 (08): : 905 - 908
  • [9] PHARMACOLOGICAL MECHANISMS OF ACTION OF FLUPIRTINE - A NOVEL, CENTRALLY ACTING, NONOPIOID ANALGESIC EVALUATED BY ITS DISCRIMINATIVE EFFECTS IN THE RAT
    SWEDBERG, MDB
    SHANNON, HE
    NICKEL, B
    GOLDBERG, SR
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1988, 246 (03): : 1067 - 1074
  • [10] Nonopioid analgesics for cancer pain: Update on clinical pharmacology
    Payne, R
    [J]. ASSESSMENT AND TREATMENT OF CANCER PAIN, 1998, 12 : 289 - 307